F. G. van den Brink

The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists.

F. G. van den Brink, 1973, European journal of pharmacology.

The antagonism between cholinomimetic agonists and beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid antagonism.

J. Offermeier, F. G. van den Brink, 1974, European journal of pharmacology.

pD2-, pA2- and pD2'-values of a series of compounds in a histaminic and a cholinergic system.

E. Lien, F. G. van den Brink, 1977, European journal of pharmacology.

The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

F. G. van den Brink, 1973, European journal of pharmacology.

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries

J. De Sutter, P. Woudstra, P. van der Harst, 2021, medRxiv.

Cumulative dose-response curves. I. Introduction to the technique.

J. V. van Rossum, F. G. van den Brink, 1963, Archives internationales de pharmacodynamie et de therapie.

The pharmacology of bronchiolar muscle relaxation.

F. G. van den Brink, 1972, Bulletin de physio-pathologie respiratoire.